Skip to main content
Erschienen in: Journal of Nephrology 5/2019

01.10.2019 | Review

When kidneys and lungs suffer together

verfasst von: Claudio Sorino, Nicola Scichilone, Claudio Pedone, Stefano Negri, Dina Visca, Antonio Spanevello

Erschienen in: Journal of Nephrology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

A significant interaction between kidneys and lungs has been shown in physiological and pathological conditions. The two organs can both be targets of the same systemic disease (eg., some vasculitides). Moreover, loss of normal function of either of them can induce direct and indirect dysregulation of the other one. Subjects suffering from COPD may have systemic inflammation, hypoxemia, endothelial dysfunction, increased sympathetic activation and increased aortic stiffness. As well as the exposure to nicotine, all the foresaid factors can induce a microvascular damage, albuminuria, and a worsening of renal function. Renal failure in COPD can be unrecognized since elderly and frail patients may have normal serum creatinine concentration. Lungs and kidneys participate in maintaining the acid-base balance. Compensatory role of the lungs rapidly expresses through an increase or reduction of ventilation. Renal compensation usually requires a few days as it is achieved through changes in bicarbonate reabsorption. Chronic kidney disease and end-stage renal diseases increase the risk of pneumonia. Vaccination against Streptococcus pneumonia and seasonal influenza is recommended for these patients. Vaccines against the last very virulent H1N1 influenza A strain are also available and effective. Acute lung injury and acute kidney injury are frequent complications in critical illnesses, associated with high morbidity and mortality. The concomitant failure of kidneys and lungs implies a multidisciplinary approach, both in terms of diagnostic processes and therapeutic management.
Literatur
1.
Zurück zum Zitat Visconti L, Santoro D, Cernaro V et al (2016) Kidney–lung connections in acute and chronic diseases: current perspectives. J Nephrol 29:341PubMed Visconti L, Santoro D, Cernaro V et al (2016) Kidney–lung connections in acute and chronic diseases: current perspectives. J Nephrol 29:341PubMed
2.
Zurück zum Zitat Binda V, Moroni G, Messa P (2018) ANCA-associated vasculitis with renal involvement. J Nephrol 31:197PubMed Binda V, Moroni G, Messa P (2018) ANCA-associated vasculitis with renal involvement. J Nephrol 31:197PubMed
3.
Zurück zum Zitat Strojek K, Ziora D, Sroczynski J, Oklek K (1992) Pulmonary complications of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:1173–1176PubMed Strojek K, Ziora D, Sroczynski J, Oklek K (1992) Pulmonary complications of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:1173–1176PubMed
4.
Zurück zum Zitat Innocenti F, Fabbri A, Anichini R et al (1994) Indications of reduced pulmonary function in type 1 (insulindependent) diabetes mellitus. Diabetes Res Clin Pract 25:161–168PubMed Innocenti F, Fabbri A, Anichini R et al (1994) Indications of reduced pulmonary function in type 1 (insulindependent) diabetes mellitus. Diabetes Res Clin Pract 25:161–168PubMed
5.
Zurück zum Zitat Mori H, Okubo M, Okamura M et al (1992) Abnormalities of pulmonary function in patients with non-insulindependent diabetes mellitus. Intern Med 31:189–193PubMed Mori H, Okubo M, Okamura M et al (1992) Abnormalities of pulmonary function in patients with non-insulindependent diabetes mellitus. Intern Med 31:189–193PubMed
6.
Zurück zum Zitat Jubic S, Metelko Z, Car N et al (1998) Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 114:1033–1035 Jubic S, Metelko Z, Car N et al (1998) Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 114:1033–1035
7.
Zurück zum Zitat Arvisi M, Bartolini L, del Borrello P et al (2001) Pulmonary function in non-insulin—dependent diabetes mellitus. Respiration 68:268–272 Arvisi M, Bartolini L, del Borrello P et al (2001) Pulmonary function in non-insulin—dependent diabetes mellitus. Respiration 68:268–272
8.
Zurück zum Zitat Sandler M (1990) Is the lung a ‘target organ’ in diabetes mellitus? Arch Intern Med 150:1385–1388PubMed Sandler M (1990) Is the lung a ‘target organ’ in diabetes mellitus? Arch Intern Med 150:1385–1388PubMed
9.
Zurück zum Zitat Gjerde B, Bakke PS, Ueland T, Hardie JA, Eagan TM (2012) The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. Respir Med 106:361–366PubMed Gjerde B, Bakke PS, Ueland T, Hardie JA, Eagan TM (2012) The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. Respir Med 106:361–366PubMed
10.
Zurück zum Zitat van Gestel YR, Chonchol M, Hoeks SE et al (2009) Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant 24:2763–2767PubMed van Gestel YR, Chonchol M, Hoeks SE et al (2009) Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant 24:2763–2767PubMed
11.
Zurück zum Zitat Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V (2010) Extrapulmonary consequences of COPD in the elderly study investigators. Chronic renal failure: a neglected comorbidity of COPD. Chest 137:831–837PubMed Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V (2010) Extrapulmonary consequences of COPD in the elderly study investigators. Chronic renal failure: a neglected comorbidity of COPD. Chest 137:831–837PubMed
12.
Zurück zum Zitat Rabe KF, Hurd S, Anzueto A et al (2007) Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: gold executive summary. Am J Respir Crit Care Med 176:532–555PubMed Rabe KF, Hurd S, Anzueto A et al (2007) Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: gold executive summary. Am J Respir Crit Care Med 176:532–555PubMed
13.
Zurück zum Zitat Mannino DM, Braman S (2007) The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4:502e6 Mannino DM, Braman S (2007) The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4:502e6
14.
Zurück zum Zitat Sorheim IC, DeMeo DL, Washko G, Litonjua A, Sparrow D, Bowler R et al (2010) Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD. COPD 7:262e8 Sorheim IC, DeMeo DL, Washko G, Litonjua A, Sparrow D, Bowler R et al (2010) Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD. COPD 7:262e8
15.
Zurück zum Zitat Fabbri LM, Luppi F, Beghé B, Rabe KF (2008) Complex chronic comorbidities of COPD. Eur Respir J 31(1):204–212PubMed Fabbri LM, Luppi F, Beghé B, Rabe KF (2008) Complex chronic comorbidities of COPD. Eur Respir J 31(1):204–212PubMed
16.
Zurück zum Zitat Huiart L, Ernst P, Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128:2640–2646PubMed Huiart L, Ernst P, Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128:2640–2646PubMed
17.
Zurück zum Zitat Fabbri LM, Rabe KF (2007) From COPD to chronic systemic inflammatory syndrome? Lancet 1(9589):797–799 370( Fabbri LM, Rabe KF (2007) From COPD to chronic systemic inflammatory syndrome? Lancet 1(9589):797–799 370(
18.
Zurück zum Zitat Barnes PJ (2013) COPD: Inflammatory mechanisms and systemic consequences. Eur Respir Monograph 59:(13–27) Barnes PJ (2013) COPD: Inflammatory mechanisms and systemic consequences. Eur Respir Monograph 59:(13–27)
19.
Zurück zum Zitat Bon JM, Zhang Y, Duncan SR et al (2010) Plasma infl ammatory mediators associated with bone metabolism in COPD. COPD 7:186–191PubMedPubMedCentral Bon JM, Zhang Y, Duncan SR et al (2010) Plasma infl ammatory mediators associated with bone metabolism in COPD. COPD 7:186–191PubMedPubMedCentral
20.
Zurück zum Zitat McAllister DA, Maclay JD, Mills NL et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176(12):1208–1214PubMedPubMedCentral McAllister DA, Maclay JD, Mills NL et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176(12):1208–1214PubMedPubMedCentral
21.
Zurück zum Zitat Elmahallawy II, Qora MA (2013) Prevalence of chronic renal failure in COPD patients. Egypt J Chest Dis Tuberc 62:221–227 Elmahallawy II, Qora MA (2013) Prevalence of chronic renal failure in COPD patients. Egypt J Chest Dis Tuberc 62:221–227
22.
Zurück zum Zitat Cooper RG (2006) Effect of tobacco smoking on renal function. Indian J Med Res 124:261–268PubMed Cooper RG (2006) Effect of tobacco smoking on renal function. Indian J Med Res 124:261–268PubMed
23.
Zurück zum Zitat Hansen HP, Rossing K, Jacobsen P, Jensen BR, Parving HH (1996) The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria. Scand J Clin Lab Invest 56:393–399PubMed Hansen HP, Rossing K, Jacobsen P, Jensen BR, Parving HH (1996) The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria. Scand J Clin Lab Invest 56:393–399PubMed
24.
Zurück zum Zitat Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL (2005) Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 128:2099–2107PubMed Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL (2005) Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 128:2099–2107PubMed
25.
Zurück zum Zitat Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574–580PubMedPubMedCentral Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574–580PubMedPubMedCentral
26.
Zurück zum Zitat Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC (2008) Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:1211–1218PubMed Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC (2008) Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:1211–1218PubMed
27.
Zurück zum Zitat Andreas S, Anker SD, Scanlon PD, Somers VK (2005) Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 128:3618–3624PubMed Andreas S, Anker SD, Scanlon PD, Somers VK (2005) Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 128:3618–3624PubMed
28.
Zurück zum Zitat Hansen JM, Olsen NV, Feldt-Rasmussen B, Kanstrup IL, Dechaux M, Dubray C, Richalet JP (1994) Albuminuria and overall capillary permeability of albumin in acute altitude hypoxia. J Appl Physiol 76:1922–1927PubMed Hansen JM, Olsen NV, Feldt-Rasmussen B, Kanstrup IL, Dechaux M, Dubray C, Richalet JP (1994) Albuminuria and overall capillary permeability of albumin in acute altitude hypoxia. J Appl Physiol 76:1922–1927PubMed
29.
Zurück zum Zitat John M, Hussain S, Prayle A, Simms R, Cockcroft JR, Bolton CE (2013) Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD. Respir Res 14:31PubMedPubMedCentral John M, Hussain S, Prayle A, Simms R, Cockcroft JR, Bolton CE (2013) Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD. Respir Res 14:31PubMedPubMedCentral
30.
Zurück zum Zitat Corsonello A, Aucella F, Pedone C, Antonelli-Incalzi R (2017) Chronic kidney disease: A likely underestimated component of multimorbidity in older patients with chronic obstructive pulmonary disease. Geriatr Gerontol Int 17:1770–1788PubMed Corsonello A, Aucella F, Pedone C, Antonelli-Incalzi R (2017) Chronic kidney disease: A likely underestimated component of multimorbidity in older patients with chronic obstructive pulmonary disease. Geriatr Gerontol Int 17:1770–1788PubMed
31.
Zurück zum Zitat Bellia V, Pistelli R, Catalano F et al (2000) Quality control of spirometry in the elderly. The SA.R.A. study. SAlute Respiration nell’Anziano = respiratory health in the elderly. Am J Respir Crit Care Med 161:1094–1100PubMed Bellia V, Pistelli R, Catalano F et al (2000) Quality control of spirometry in the elderly. The SA.R.A. study. SAlute Respiration nell’Anziano = respiratory health in the elderly. Am J Respir Crit Care Med 161:1094–1100PubMed
32.
Zurück zum Zitat Almagro P, Calbo E, Ochoa de Echagüen A et al (2002) Mortality after hospitalization for COPD. Chest 121(5):1441–1448PubMed Almagro P, Calbo E, Ochoa de Echagüen A et al (2002) Mortality after hospitalization for COPD. Chest 121(5):1441–1448PubMed
33.
Zurück zum Zitat Middleton RJ, Foley RN, Hegarty J et al (2006) The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant 21:88–92PubMed Middleton RJ, Foley RN, Hegarty J et al (2006) The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant 21:88–92PubMed
34.
Zurück zum Zitat Corsonello A, Pedone C, Bandinelli S, Ferrucci L, Antonelli Incalzi R (2017) Agreement between chronic kidney disease epidemiological collaboration and Berlin initiative study equations for estimating glomerular filtration rate in older people: the Invecchiare in Chianti (aging in Chianti region) study. Geriatr Gerontol Int 17(10):1559–1567PubMed Corsonello A, Pedone C, Bandinelli S, Ferrucci L, Antonelli Incalzi R (2017) Agreement between chronic kidney disease epidemiological collaboration and Berlin initiative study equations for estimating glomerular filtration rate in older people: the Invecchiare in Chianti (aging in Chianti region) study. Geriatr Gerontol Int 17(10):1559–1567PubMed
35.
Zurück zum Zitat McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (8):1004–1009PubMed McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (8):1004–1009PubMed
36.
Zurück zum Zitat Bruno CM, Valenti MJ (2012) Acid–base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review. Biomed Biotechnol 2012:915150. Epub 2012 Feb 1 Bruno CM, Valenti MJ (2012) Acid–base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review. Biomed Biotechnol 2012:915150. Epub 2012 Feb 1
37.
Zurück zum Zitat Ucgun I, Oztuna F, Dagli CE, Yildirim H, Bal C (2008) Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia. Respiration 76(3):270–274.(Epub 2008 May 8)PubMed Ucgun I, Oztuna F, Dagli CE, Yildirim H, Bal C (2008) Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia. Respiration 76(3):270–274.(Epub 2008 May 8)PubMed
38.
Zurück zum Zitat Handy JM, Soni N (2008) Physiological effects of hyperchloraemia and acidosis. Br J Anaesth 101(2):141–150PubMed Handy JM, Soni N (2008) Physiological effects of hyperchloraemia and acidosis. Br J Anaesth 101(2):141–150PubMed
39.
Zurück zum Zitat Kraut JA, Madias NE (2010) Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 6(5):274–285PubMed Kraut JA, Madias NE (2010) Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 6(5):274–285PubMed
40.
Zurück zum Zitat Anand IS, Chandrashekhar Y, Ferrari R et al (1992) Pathogenesis of congestive state in chronic obstructive pulmonary disease: studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 86(1):12–21PubMed Anand IS, Chandrashekhar Y, Ferrari R et al (1992) Pathogenesis of congestive state in chronic obstructive pulmonary disease: studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 86(1):12–21PubMed
41.
Zurück zum Zitat Ucgun I, Oztuna F, Dagli CE, Yildirim H, Bal C (2008) Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia. Respiration 76(3):270–274PubMed Ucgun I, Oztuna F, Dagli CE, Yildirim H, Bal C (2008) Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia. Respiration 76(3):270–274PubMed
42.
Zurück zum Zitat Khilnani GC, Banga A, Sharma SK (2004) Predictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: a one year study. BMC Pulm Med 4:12PubMedPubMedCentral Khilnani GC, Banga A, Sharma SK (2004) Predictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: a one year study. BMC Pulm Med 4:12PubMedPubMedCentral
43.
Zurück zum Zitat Banga A, Khilnani GC (2006) A comparative study of characteristics and outcome of patients with acute respiratory failure and acute on chronic respiratory failure requiring mechanical ventilation. Indian J Crit Care Med 10(2):80–87 Banga A, Khilnani GC (2006) A comparative study of characteristics and outcome of patients with acute respiratory failure and acute on chronic respiratory failure requiring mechanical ventilation. Indian J Crit Care Med 10(2):80–87
44.
Zurück zum Zitat Karacan O, Tutal E, Colak T et al (2006) Pulmonary function in renal transplant recipients and endstage renal disease patients undergoing maintenance dialysis. Transpl Proc 38:396–400 Karacan O, Tutal E, Colak T et al (2006) Pulmonary function in renal transplant recipients and endstage renal disease patients undergoing maintenance dialysis. Transpl Proc 38:396–400
45.
Zurück zum Zitat Gómez-Fernández P, Sánchez Agudo L, Calatrava JM et al (1984) Respiratory muscle weakness in uremic patients under continuous ambulatory peritoneal dialysis. Nephron 36:219–223PubMed Gómez-Fernández P, Sánchez Agudo L, Calatrava JM et al (1984) Respiratory muscle weakness in uremic patients under continuous ambulatory peritoneal dialysis. Nephron 36:219–223PubMed
46.
Zurück zum Zitat Manfredini F, Lamberti N, Malagoni AM et al (2015) The role of deconditioning in the end-stage renal disease myopathy: physical exercise improves altered resting muscle oxygen consumption. Am J Nephrol 41:329–336PubMed Manfredini F, Lamberti N, Malagoni AM et al (2015) The role of deconditioning in the end-stage renal disease myopathy: physical exercise improves altered resting muscle oxygen consumption. Am J Nephrol 41:329–336PubMed
47.
Zurück zum Zitat Pomidori L, Lamberti N, Malagoni AM et al (2016) Respiratory muscle impairment in dialysis patients: can minimal dose of exercise limit the damage? A Preliminary study in a sample of patients enrolled in the EXCITE trial. J Nephrol 29:863–869PubMed Pomidori L, Lamberti N, Malagoni AM et al (2016) Respiratory muscle impairment in dialysis patients: can minimal dose of exercise limit the damage? A Preliminary study in a sample of patients enrolled in the EXCITE trial. J Nephrol 29:863–869PubMed
48.
Zurück zum Zitat Turner C, Spanel P, Smith D (2006) A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry, SIFT-MS. Physiol Meas 27(4):321–337PubMed Turner C, Spanel P, Smith D (2006) A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry, SIFT-MS. Physiol Meas 27(4):321–337PubMed
49.
Zurück zum Zitat Narasimhan LR, Goodman W, Patel CK (2001) Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis. Proc Natl Acad Sci USA 98(8): 4617–4621PubMed Narasimhan LR, Goodman W, Patel CK (2001) Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis. Proc Natl Acad Sci USA 98(8): 4617–4621PubMed
50.
Zurück zum Zitat Simenhoff ML, Burke JF, Saukkonen JJ et al (1977) Biochemical profile of uremic breath. N Engl J Med 297(3):132–135PubMed Simenhoff ML, Burke JF, Saukkonen JJ et al (1977) Biochemical profile of uremic breath. N Engl J Med 297(3):132–135PubMed
51.
Zurück zum Zitat Davies SJ, Španěl P, Smith D (2014) Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis. Bioanalysis 6(6):843–857PubMed Davies SJ, Španěl P, Smith D (2014) Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis. Bioanalysis 6(6):843–857PubMed
52.
Zurück zum Zitat Jankowski J, Westhof T, Vaziri ND et al (2014) Gases as uremic toxins: is there something in the air? Semin Nephrol 34(2):135–150PubMed Jankowski J, Westhof T, Vaziri ND et al (2014) Gases as uremic toxins: is there something in the air? Semin Nephrol 34(2):135–150PubMed
53.
Zurück zum Zitat Holland AE, Wilson JW, Kotsimbos TC, Naughton MT. (2003). Metabolic alkalosis contributes to acute hypercapnic respiratory failure in adult cystic fibrosis. Chest 124(2):490–493PubMed Holland AE, Wilson JW, Kotsimbos TC, Naughton MT. (2003). Metabolic alkalosis contributes to acute hypercapnic respiratory failure in adult cystic fibrosis. Chest 124(2):490–493PubMed
54.
Zurück zum Zitat Sbardella E, Isidori AM, Arnaldi G et al (2018 Jan) Approach to hyponatremia according to the clinical setting: consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). J Endocrinol Invest 41(1):3–19PubMed Sbardella E, Isidori AM, Arnaldi G et al (2018 Jan) Approach to hyponatremia according to the clinical setting: consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). J Endocrinol Invest 41(1):3–19PubMed
55.
Zurück zum Zitat Naqvi SB, Collins AJ (2006) Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 13(3):199PubMed Naqvi SB, Collins AJ (2006) Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 13(3):199PubMed
56.
Zurück zum Zitat Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG (2012) The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis 59(3):356PubMed Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG (2012) The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis 59(3):356PubMed
57.
Zurück zum Zitat Eleftheriadis T, Liakopoulos V, Leivaditis K et al. (2011) Infections in hemodialysis: a concise review—part 1: bacteremia and respiratory infections. Hippokratia 15(1): 12–17PubMedPubMedCentral Eleftheriadis T, Liakopoulos V, Leivaditis K et al. (2011) Infections in hemodialysis: a concise review—part 1: bacteremia and respiratory infections. Hippokratia 15(1): 12–17PubMedPubMedCentral
58.
Zurück zum Zitat Sarnak MJ, Jaber BL (2001) Pulmonary infectious mortality among patients with end-stage renal disease. Chest 120:1883–1887PubMed Sarnak MJ, Jaber BL (2001) Pulmonary infectious mortality among patients with end-stage renal disease. Chest 120:1883–1887PubMed
59.
Zurück zum Zitat Robinson J (2004) Efficacy of pneumococcal immunization in patients with renal disease—what is the data? Am J Nephrol 24:402–409PubMed Robinson J (2004) Efficacy of pneumococcal immunization in patients with renal disease—what is the data? Am J Nephrol 24:402–409PubMed
60.
Zurück zum Zitat Tanzi E, Amendola A, Pariani E, Zappa A, Colzani D, Logias F et al (2007) Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. J Med Virol 79:1176–1179PubMed Tanzi E, Amendola A, Pariani E, Zappa A, Colzani D, Logias F et al (2007) Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. J Med Virol 79:1176–1179PubMed
61.
Zurück zum Zitat Poduval RD, Hammes MD (2003) Tuberculosis screening in dialysis patients—is the tuberculin test effective? Clin Nephrol 59:436–440PubMed Poduval RD, Hammes MD (2003) Tuberculosis screening in dialysis patients—is the tuberculin test effective? Clin Nephrol 59:436–440PubMed
62.
Zurück zum Zitat Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G et al (2008) Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 3:1357–1363PubMedPubMedCentral Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G et al (2008) Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 3:1357–1363PubMedPubMedCentral
63.
Zurück zum Zitat Pencheva VP, Petrova DS, Genov DK et al (2015) Risk factors for lung diseases after renal transplantation. J Res Med Sci 20(12):1127–1132PubMedPubMedCentral Pencheva VP, Petrova DS, Genov DK et al (2015) Risk factors for lung diseases after renal transplantation. J Res Med Sci 20(12):1127–1132PubMedPubMedCentral
64.
Zurück zum Zitat Canet E, Osman D, Lambert J et al (2011) Acute respiratory failure in kidney transplant recipients: a multicenter study. Crit Care 15(2):R91PubMedPubMedCentral Canet E, Osman D, Lambert J et al (2011) Acute respiratory failure in kidney transplant recipients: a multicenter study. Crit Care 15(2):R91PubMedPubMedCentral
65.
Zurück zum Zitat Pencheva V, Petrova D, Genov D et al (2014) Pulmonary complications as a cause of death after renal transplantation. Open J Intern Med 4:41–46 Pencheva V, Petrova D, Genov D et al (2014) Pulmonary complications as a cause of death after renal transplantation. Open J Intern Med 4:41–46
66.
Zurück zum Zitat Zeyneloglu P (2015) Respiratory complications after solid-organ transplantation. Exp Clin Transpl 13(2):115–125 Zeyneloglu P (2015) Respiratory complications after solid-organ transplantation. Exp Clin Transpl 13(2):115–125
67.
Zurück zum Zitat Kupeli E, Ulubay G, Colak T et al (2011) Pulmonary complications in renal recipients after transplantation. Transpl Proc 43(2):551–553 Kupeli E, Ulubay G, Colak T et al (2011) Pulmonary complications in renal recipients after transplantation. Transpl Proc 43(2):551–553
68.
Zurück zum Zitat Splendiani G, Cipriani S, Tisone G et al (2005) Infectious complications in renal transplant recipients. Transpl Proc 37(6):2497–2499 Splendiani G, Cipriani S, Tisone G et al (2005) Infectious complications in renal transplant recipients. Transpl Proc 37(6):2497–2499
69.
Zurück zum Zitat Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 357:2601–2614PubMed Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 357:2601–2614PubMed
70.
Zurück zum Zitat Sasaki T, Nakamura W, Inokuma S et al (2016) Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients. Clin Rheumatol 35(2):541–545PubMed Sasaki T, Nakamura W, Inokuma S et al (2016) Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients. Clin Rheumatol 35(2):541–545PubMed
71.
Zurück zum Zitat Boddana P, Webb LH, Unsworth J et al (2011) Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon? Clin Transpl 25(3):417–419 Boddana P, Webb LH, Unsworth J et al (2011) Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon? Clin Transpl 25(3):417–419
72.
Zurück zum Zitat Gorgan M, Bockorny B, Lawlor M et al (2013) Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. Arch Pathol Lab Med 137(11):1684–1687PubMed Gorgan M, Bockorny B, Lawlor M et al (2013) Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. Arch Pathol Lab Med 137(11):1684–1687PubMed
73.
Zurück zum Zitat Tomei P, Masola V, Granata S et al (2016) Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation. J Nephrol 29:881PubMed Tomei P, Masola V, Granata S et al (2016) Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation. J Nephrol 29:881PubMed
74.
Zurück zum Zitat Solazzo A, Botta C, Nava F et al. (2016) Interstitial lung disease after kidney transplantation and the role of Everolimus. Transpl Proc 48(2):349–351 Solazzo A, Botta C, Nava F et al. (2016) Interstitial lung disease after kidney transplantation and the role of Everolimus. Transpl Proc 48(2):349–351
75.
Zurück zum Zitat Faubel S, Edelstein CL (2016 Jan) Mechanisms and mediators of lung injury after acute kidney injury. Nat Rev Nephrol 12(1):48–60PubMed Faubel S, Edelstein CL (2016 Jan) Mechanisms and mediators of lung injury after acute kidney injury. Nat Rev Nephrol 12(1):48–60PubMed
76.
Zurück zum Zitat Dushianthan A, Grocott MP, Postle AD, Cusack R (2011) Acute respiratory distress syndrome and acute lung injury. Postgrad Med J 87(1031):612–622PubMed Dushianthan A, Grocott MP, Postle AD, Cusack R (2011) Acute respiratory distress syndrome and acute lung injury. Postgrad Med J 87(1031):612–622PubMed
77.
Zurück zum Zitat Srisawat N, Kellum JA (2011) Acute kidney injury: definition, epidemiology, and outcome. Curr Opin Crit Care 17(6):548–555PubMed Srisawat N, Kellum JA (2011) Acute kidney injury: definition, epidemiology, and outcome. Curr Opin Crit Care 17(6):548–555PubMed
78.
Zurück zum Zitat Koyner JL, Murray PT (2010) Mechanical ventilation and the kidney. Blood Purif 29:52–68PubMed Koyner JL, Murray PT (2010) Mechanical ventilation and the kidney. Blood Purif 29:52–68PubMed
79.
Zurück zum Zitat Pannu N et al (2004) Effect of mechanical ventilation on the kidney. Best Pract Res Clin Anaesthesiol 18:189–203PubMed Pannu N et al (2004) Effect of mechanical ventilation on the kidney. Best Pract Res Clin Anaesthesiol 18:189–203PubMed
Metadaten
Titel
When kidneys and lungs suffer together
verfasst von
Claudio Sorino
Nicola Scichilone
Claudio Pedone
Stefano Negri
Dina Visca
Antonio Spanevello
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 5/2019
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-018-00563-1

Weitere Artikel der Ausgabe 5/2019

Journal of Nephrology 5/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.